Nuwellis (NUWE)
(Delayed Data from NSDQ)
$1.81 USD
+0.05 (2.84%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $1.88 +0.07 (3.87%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth B Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/11/2024
Time: BMO |
9/2024 | $-0.88 | 0.00% |
Earnings Summary
For their last quarter, Nuwellis (NUWE) reported earnings of -$18.85 per share, missing the Zacks Consensus Estimate of -$9.49 per share. This reflects a negative earnings surprise of 98.63%. Look out for NUWE's next earnings release on November 11, 2024. For the next earning release, we expect the company to report earnings of -$0.88 per share, reflecting a year-over-year increase of 98.61%.
Earnings History
Price & Consensus
Zacks News for NUWE
Tandem Diabetes Care, Inc. (TNDM) Reports Q3 Loss, Tops Revenue Estimates
NUWE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why Nuwellis, Inc. (NUWE) Is a Great 'Buy the Bottom' Stock Now
NUWE FAQs
Nuwellis, Inc. (NUWE) has announced they will report their next quarter earnings on November 11, 2024. For the next earning release, we expect the company to report earnings of $-0.88 per share, reflecting a year-over-year increase of 98.61%.
Nuwellis, Inc. has announced they will report their previous quarter earnings after the close of the market on November 11, 2024.
The Zacks Consensus Estimate for Nuwellis, Inc. (NUWE) for the quarter ending September 2024 is $-0.88 a share. We expect Nuwellis, Inc. (NUWE) to report earnings in line with the consensus estimate of $-0.88 per share
In the earnings report for the quarter ending in June 2024, Nuwellis, Inc. (NUWE) announced earnings of $-18.85 per share versus the Zacks Consensus Estimate of $-9.49 per share, representing a surprise of 98.63%.